Recruiting NA Cancer

New treatment option for Cancer

Official title Deployment of Teleconsulting in Geriatric Oncology for Older Patients

ClinicalTrials.gov ID: NCT05619731

What this study is testing

What it's testing
Cancer affects mostly older adults. The development of Geriatric Oncology has greatly improved the management of older patients with the Comprehensive Geriatric Assessments (CGA) being conducted before cancer treatment.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 75 and older

You may be able to join if

  • Patients 75 years and older
  • Suffering from all types and all stages of cancer and treated for cancer in participating centers
  • G8 (screening tool) ≤ 14/17
  • Agreeing to benefit from a geriatric oncology assessment
  • Having signed a consent

You likely can't join if

  • Patients under guardianship or curatorship or inability to sign consent
  • Patients with severe cognitive impairment (MMSE \< 10/30)
  • Patients with severe hearing or visual impairments as these patients will have difficulty performing the telemedicine consultation
  • Patients with a significant language barrier without an interpreter present because these patients will have difficulty carrying out the Telemedicine...
  • Patients with expectancy less than 3 months
See the full eligibility criteria
Who can join
  • Patients 75 years and older
  • Suffering from all types and all stages of cancer and treated for cancer in participating centers
  • G8 (screening tool) ≤ 14/17
  • Agreeing to benefit from a geriatric oncology assessment
  • Having signed a consent
  • Affiliated to French social security or a similar French solidarity scheme
What rules you out
  • Patients under guardianship or curatorship or inability to sign consent
  • Patients with severe cognitive impairment (MMSE \< 10/30)
  • Patients with severe hearing or visual impairments as these patients will have difficulty performing the telemedicine consultation
  • Patients with a significant language barrier without an interpreter present because these patients will have difficulty carrying out the Telemedicine consultation
  • Patients with expectancy less than 3 months

The study team makes the final eligibility decision.

Where it's taking place

  • Avignon, France

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 75 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Avignon, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.